Affordable Access

deepdyve-link
Publisher Website

Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

Authors
  • Formiga, Fabio Rocha1, 2
  • Leblanc, Roger3
  • de Souza Rebouças, Juliana4
  • Farias, Leonardo Paiva5
  • de Oliveira, Ronaldo Nascimento6
  • Pena, Lindomar7
  • 1 Department of Immunology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), 50670-420 Recife, PE, Brazil
  • 2 Graduate Program in Applied Cellular and Molecular Biology, University of Pernambuco (UPE), 50100-130 Recife, PE, Brazil
  • 3 Department of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, FL 33146, USA
  • 4 Institute of Biological Sciences, University of Pernambuco (UPE), 50100-130 Recife, PE, Brazil
  • 5 Laboratory of Inflammation and Biomarkers, Gonçalo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), 40296-710 Salvador, BA, Brazil
  • 6 Bioactive Compounds Synthesis Laboratory, Department of Chemistry, Federal Rural University of Pernambuco (UFRPE), 52171-900 Recife, PE, Brazil
  • 7 Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), 50670-420 Recife, PE, Brazil
Type
Published Article
Journal
Journal of controlled release : official journal of the Controlled Release Society
Publication Date
Oct 07, 2020
Volume
329
Pages
758–761
Identifiers
DOI: 10.1016/j.jconrel.2020.10.009
PMID: 33038449
PMCID: PMC7539925
Source
PubMed Central
License
Unknown

Abstract

Unlabelled Image

Report this publication

Statistics

Seen <100 times